Emin Evren Ozcan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emin Evren Ozcan has a total of 305 co-authors. Here are the top co-authors by number of shared publications:
- Oguzhan Ekrem Turan
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye
13 shared publications - Gábor Széplaki
Mater Private Hospital and Royal College of Surgeons in Ireland , Dublin
12 shared publications - Reşit Yiğit Yılancıoğlu
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye
11 shared publications Béla Merkely
Department of Cardiology, The Heart and Vascular Center of Semmelweis University, Városmajor street 68, Budapest H, Hungary
7 shared publicationsIstván Osztheimer
Department of Cardiology, The Heart and Vascular Center of Semmelweis University, Városmajor street 68, Budapest H, Hungary
7 shared publications- László Gellér
Heart and Vascular Center, Semmelweis University, Budapest, Hungary
7 shared publications
Latest Publications
- 23 January 2026
- Published by Elsevier in Heart Rhythm
- Vol. 23 (8) , e1453-e1464
Hemolysis and renal safety of pulsed-field vs thermal ablation for atrial fibrillation: A systematic review and meta-analysis
- 23 January 2026
- Published by Elsevier in Heart Rhythm
- Vol. 23 (8) , e1453-e1464
Hemolysis and renal safety of pulsed-field vs thermal ablation for atrial fibrillation: A systematic review and meta-analysis
- 6 January 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (3) , 321-323
GLP-1 receptor agonist therapy is associated with reduced atrial fibrillation recurrence after catheter ablation: a meta-analysis
- 6 January 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (3) , 321-323
GLP-1 receptor agonist therapy is associated with reduced atrial fibrillation recurrence after catheter ablation: a meta-analysis
- Open Access
- 7 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (10)
Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study
- 7 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (10)
Open AccessInfluence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study
- 7 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (12) , 3249-3260
Fluoroscopy Integration Module Enhanced Localization of Intramural Premature Ventricular Complex in Ethanol Ablation
Aims: The Fluoroscopy Integration Module (FIM) is a novel feature in electroanatomic mapping systems that enhances real‐time visualization of coronary venous anatomy during mapping and ablation of intramural premature ventricular complexes (PVCs). This report demonstrates the clinical utility of FIM in guiding side branch vein selection and precise ethanol ablation targeting for intramural PVCs. Methods and Results: The target venous branch was selected under FIM guidance in patients with intramural PVCs where RF ablation failed. Ethanol was applied to the venous branch extending to the center of the intersection of ablation tags or early activation areas where transient suppression occurred. Conclusion: The fluoroscopy integration module significantly improves procedural precision in targeting intramural PVCs, facilitating effective ethanol ablation and optimizing clinical success.
- 7 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (12) , 3249-3260
Fluoroscopy Integration Module Enhanced Localization of Intramural Premature Ventricular Complex in Ethanol Ablation
Aims: The Fluoroscopy Integration Module (FIM) is a novel feature in electroanatomic mapping systems that enhances real‐time visualization of coronary venous anatomy during mapping and ablation of intramural premature ventricular complexes (PVCs). This report demonstrates the clinical utility of FIM in guiding side branch vein selection and precise ethanol ablation targeting for intramural PVCs. Methods and Results: The target venous branch was selected under FIM guidance in patients with intramural PVCs where RF ablation failed. Ethanol was applied to the venous branch extending to the center of the intersection of ablation tags or early activation areas where transient suppression occurred. Conclusion: The fluoroscopy integration module significantly improves procedural precision in targeting intramural PVCs, facilitating effective ethanol ablation and optimizing clinical success.
- 7 May 2025
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 81, 102097
Diagnostic accuracy of machine learning algorithms in electrocardiogram-based sleep apnea detection: A systematic review and meta-analysis
- 7 May 2025
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 81, 102097
Diagnostic accuracy of machine learning algorithms in electrocardiogram-based sleep apnea detection: A systematic review and meta-analysis
- 21 April 2025
- Published by Springer Nature in Journal of Medical and Biological Engineering
- Vol. 45 (2) , 314-324
Explainable AI for Specific Arrhythmia Detection: SHAP-Based Insights from Multi-Lead ECG Data
- 21 April 2025
- Published by Springer Nature in Journal of Medical and Biological Engineering
- Vol. 45 (2) , 314-324
Explainable AI for Specific Arrhythmia Detection: SHAP-Based Insights from Multi-Lead ECG Data
- Open Access
- 12 July 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (28) , e38839
Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study
Left ventricular assist devices (LVADs) are widely used as end-stage therapy in patients with advanced heart failure, whereas implantation increases the risks of development of sustained ventricular tachycardia at the later postimplantation stage. Therefore, this study aimed to evaluate the clinical efficacy of orally administered amiodarone and propranolol in 3 patients with ventricular tachycardia (VT) after LVAD implantation who were resistant to initial anti-antiarrhythmic drugs. This retrospective cohort study consisted of the initial evaluation of the clinical data of 14 adult patients who underwent implantation of LVAD between January 2019 and March 2021. A total of 3 patients with resistant VT were finally included. In all cases, the patients were initially administered amiodarone in the different doses intravenously to stabilize the critical condition, whereas its oral form along with that of propranolol was used as maintenance therapy in the first 2 cases. In the third case, amiodarone was withdrawn because of the risk of development of hyperthyroidism, while oral propranolol was used in the treatment. The assessment in the 16-month follow-up period after discharge did not show presence of non-sustained and sustained VT in all 3 cases. In the ventricular arrhythmia-free group, the total mortality rate within the follow-up period was 11.1 ± 7.78 months in the 3 patients. We suggest that maintenance oral therapy of propranolol and amiodarone can significantly decrease the risks of complications in patients with VT after implantation of ventricular assist device in the long term.
- 12 July 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (28) , e38839
Open AccessOral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study
Left ventricular assist devices (LVADs) are widely used as end-stage therapy in patients with advanced heart failure, whereas implantation increases the risks of development of sustained ventricular tachycardia at the later postimplantation stage. Therefore, this study aimed to evaluate the clinical efficacy of orally administered amiodarone and propranolol in 3 patients with ventricular tachycardia (VT) after LVAD implantation who were resistant to initial anti-antiarrhythmic drugs. This retrospective cohort study consisted of the initial evaluation of the clinical data of 14 adult patients who underwent implantation of LVAD between January 2019 and March 2021. A total of 3 patients with resistant VT were finally included. In all cases, the patients were initially administered amiodarone in the different doses intravenously to stabilize the critical condition, whereas its oral form along with that of propranolol was used as maintenance therapy in the first 2 cases. In the third case, amiodarone was withdrawn because of the risk of development of hyperthyroidism, while oral propranolol was used in the treatment. The assessment in the 16-month follow-up period after discharge did not show presence of non-sustained and sustained VT in all 3 cases. In the ventricular arrhythmia-free group, the total mortality rate within the follow-up period was 11.1 ± 7.78 months in the 3 patients. We suggest that maintenance oral therapy of propranolol and amiodarone can significantly decrease the risks of complications in patients with VT after implantation of ventricular assist device in the long term.
- Open Access
- 24 May 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (Supplement)
Effect of implantable cardioverter defibrillator intracardiac electrogram morphology changes on hospitalization and life quality
Background: Implantable Cardioverter Defibrillators (ICD) are standard therapy for patients at risk of life-threatening ventricular tachyarrhythmias. ICDs use morphology discrimination to compare ventricular electrogram during tachycardia with reference template during baseline rhythm. Baseline morphology match score (MMS) changes may predict arrhythmic events, but usefulness as a parameter for heart failure (HF) is still unknown. Methods: The prospective single-center study included consecutive 88 patients undergoing device control at cardiology department from July 2022 to May 2023. Inclusion criteria were patients implanted with ICD or CRT for at least 3 months; the exclusion criteria were defined as communication barriers (n=1), depleted device battery during checks (n=1), total AV block (n=3), and auto-template activation (n=4). The data were analysed for changes in the baseline (MMS) relationship with demographic, clinical characteristics, quality of life (QOL), and hospitalisation with HF. Results: We analyzed 79 patients with a mean age 64,9 13,6 and an average MMS of 98 1,8 morphology. During follow-up there were 12 (15%) patients hospitalized due to HF. ROC curve analysis showed that a MMS ≤ 97% had 73% sensitivity and 59% specificity for hospitalization (p: 0,033 Area 0.695). No significant differences were observed in demographics between the two groups. Although there was no significant difference in EF and BNP levels, patients with MMS <97% had lower QOL scores and more hospitalizations for heart failure (HF). Conclusion: EGM baseline MMS changes in ICD were associated with hospitalization for HF and QOL, apart from arrhythmia detection indications. It may be a follow-up parameter for HF, in addition to the current device algorithms.Graphical AbstractTable 1
- 24 May 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (Supplement)
Open AccessEffect of implantable cardioverter defibrillator intracardiac electrogram morphology changes on hospitalization and life quality
Background: Implantable Cardioverter Defibrillators (ICD) are standard therapy for patients at risk of life-threatening ventricular tachyarrhythmias. ICDs use morphology discrimination to compare ventricular electrogram during tachycardia with reference template during baseline rhythm. Baseline morphology match score (MMS) changes may predict arrhythmic events, but usefulness as a parameter for heart failure (HF) is still unknown. Methods: The prospective single-center study included consecutive 88 patients undergoing device control at cardiology department from July 2022 to May 2023. Inclusion criteria were patients implanted with ICD or CRT for at least 3 months; the exclusion criteria were defined as communication barriers (n=1), depleted device battery during checks (n=1), total AV block (n=3), and auto-template activation (n=4). The data were analysed for changes in the baseline (MMS) relationship with demographic, clinical characteristics, quality of life (QOL), and hospitalisation with HF. Results: We analyzed 79 patients with a mean age 64,9 13,6 and an average MMS of 98 1,8 morphology. During follow-up there were 12 (15%) patients hospitalized due to HF. ROC curve analysis showed that a MMS ≤ 97% had 73% sensitivity and 59% specificity for hospitalization (p: 0,033 Area 0.695). No significant differences were observed in demographics between the two groups. Although there was no significant difference in EF and BNP levels, patients with MMS <97% had lower QOL scores and more hospitalizations for heart failure (HF). Conclusion: EGM baseline MMS changes in ICD were associated with hospitalization for HF and QOL, apart from arrhythmia detection indications. It may be a follow-up parameter for HF, in addition to the current device algorithms.Graphical AbstractTable 1
- 27 October 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (12) , 2573-2580
Combining conventional technique with fluoroscopy integration module in accessory pathway ablation
Introduction: Accessory pathway (AP) ablation is a straightforward approach with high success rates, but the fluoroscopy time (FT) is significantly longer in conventional technique. Electroanatomical mapping systems (EMS), reduce the FT, but anatomical and activation mapping may prolong the procedure time (PT). The fluoroscopy integration module (FIM) uses prerecorded fluoroscopy images and allows ablation similar to conventional technique without creating an anatomical map. In this study, we investigated the effects of combining the FIM with traditional technique on PT, success, and radiation exposure.Methods: A total of 131 patients who had undergone AP ablation were included in our study. In 37 patients, right and left anterior oblique (RAO‐LAO) images were acquired after catheter placement and integrated with the FIM. The ablation procedure was then similar to the conventional technique, but without the use of fluoroscopy. For the purpose of acceleration, anatomical and activation maps have not been created. Contact‐force catheters were not used. 94 patients underwent conventional ablation using fluoroscopy only.Results: FIM into AP ablation procedures led to a significant reduction in radiation exposure, lowering FT from 7.4 to 2.8 min (p < .001) and dose‐area product from 12.47 to 5.8 μGym² (p < .001). While the FIM group experienced a reasonable longer PT (69 vs. 50 min p < .001). FIM reduces FT regardless of operator experience and location of APsConclusion: Combining FIM integration with conventional AP ablation offers reduced radiation exposure without compromising success rates and complication.
- 27 October 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (12) , 2573-2580
Combining conventional technique with fluoroscopy integration module in accessory pathway ablation
Introduction: Accessory pathway (AP) ablation is a straightforward approach with high success rates, but the fluoroscopy time (FT) is significantly longer in conventional technique. Electroanatomical mapping systems (EMS), reduce the FT, but anatomical and activation mapping may prolong the procedure time (PT). The fluoroscopy integration module (FIM) uses prerecorded fluoroscopy images and allows ablation similar to conventional technique without creating an anatomical map. In this study, we investigated the effects of combining the FIM with traditional technique on PT, success, and radiation exposure.Methods: A total of 131 patients who had undergone AP ablation were included in our study. In 37 patients, right and left anterior oblique (RAO‐LAO) images were acquired after catheter placement and integrated with the FIM. The ablation procedure was then similar to the conventional technique, but without the use of fluoroscopy. For the purpose of acceleration, anatomical and activation maps have not been created. Contact‐force catheters were not used. 94 patients underwent conventional ablation using fluoroscopy only.Results: FIM into AP ablation procedures led to a significant reduction in radiation exposure, lowering FT from 7.4 to 2.8 min (p < .001) and dose‐area product from 12.47 to 5.8 μGym² (p < .001). While the FIM group experienced a reasonable longer PT (69 vs. 50 min p < .001). FIM reduces FT regardless of operator experience and location of APsConclusion: Combining FIM integration with conventional AP ablation offers reduced radiation exposure without compromising success rates and complication.